Fluidic Analytics: Joe Keegan
Fluidic Analytics has appointed Joe Keegan as the firm's chairman. Keegan currently serves on the boards of Bio-Techne and Interpace Diagnostics, as well as a number of early- and growth-stage companies in the life sciences tools and diagnostic industries. Prior to Fluidic Analytics, Keegan served as CEO as ForteBio until it was sold to Pall Corporation. Before ForteBio, Keegan was CEO of Molecular Devices. Keegan has also held the role of chairman of the Analytical Life Science & Diagnostics Association, non-executive chairman of Labcyte, and non-executive director of Advanced Cellular Diagnostics, ProteinSimple, and Seahorse Bioscience.